InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.24
(
0.00%
)
US TECH 100
17,736.00
(
0.07%
)
Dow Jones
39,392.55
(
-0.10%
)
Brent Oil
82.14
(
-1.29%
)
Bitcoin
61,387.14
(
-2.41%
)
Post# of 10798
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bobwins

Send PM Follow Ignore
Followers 556
Posts 17435
Boards Moderated 42
Alias Born 10/21/2003

Bobwins

Re: Bobwins post# 10556

Thursday, 04/18/2019 3:14:54 PM

Thursday, April 18, 2019 3:14:54 PM

Post# of 10798
ate.v/atbpf +.01 to C$.325



paid interview with CEO of Antibe. Not the most exciting public speaker but highlights the upcoming catalysts for Antibe drug ATB-346 potentially entering phase III trials by late 2019.

Doing last testing prior to engaging in negotiations with big Pharma to do phase III trial of naproxen derivative.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up